Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fantoni

Showing results (761-770 of 857) with videos related to

Pageof 86
Sort By:
Nature Communications|February 23, 2016
Genome analysis of three Pneumocystis species reveals adaptation mechanisms to life exclusively in mammalian hostsLiang Ma, Zehua Chen, Da Wei Huang, et al.
Nature Immunology|January 5, 2021
Broadly effective metabolic and immune recovery with C5 inhibition in CHAPLE diseaseAhmet Ozen, Nurhan Kasap, Ivan Vujkovic-Cvijin, et al.
Eclinicalmedicine|January 2, 2023
Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trialKarolina Akinosoglou, Antigone Kotsaki, Ioanna-Maria Gounaridi, et al.
Research Square|March 30, 2023
Multiomics integration of 22 immune-mediated monogenic diseases reveals an emergent axis of human immune healthRachel Sparks, Nicholas Rachmaninoff, Dylan C Hirsch, et al.
Nature Medicine|July 3, 2024
A unified metric of human immune healthRachel Sparks, Nicholas Rachmaninoff, William W Lau, et al.
World Journal of Emergency Surgery : WJES|February 20, 2020
A proposal for a comprehensive approach to infections across the surgical pathwayMassimo Sartelli, Leonardo Pagani, Stefania Iannazzo, et al.
Nature Medicine|September 4, 2021
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trialEvdoxia Kyriazopoulou, Garyfallia Poulakou, Haralampos Milionis, et al.
Vaccine|September 4, 2023
Timeline kinetics of protective immunity to SARS-CoV-2 upon primary vaccination and humoral response to variants after booster doseMaria da Penha Gomes Gouvea, Ketty Lysie Libardi Lira Machado, Yasmin Gurtler Pinheiro de Oliveira, et al.
Vaccines|November 26, 2025
Third Booster Half Dose of ChAdOx1-nCov-19 Is Effective, Safe, and Induces Long-Duration Humoral and Cellular Immune Response to Omicron: 1-Year Follow-Up of Viana StudyNésio Fernandes de Medeiros-Junior, Maria da Penha Gomes Gouvea, Luiz Antônio Bastos Camacho, et al.
Thrombosis and Haemostasis|January 7, 2021
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST StudyAugusto Di Castelnuovo, Simona Costanzo, Andrea Antinori, et al.
Pageof 86

Showing results (761-770 of 857) with videos related to

Sort By:
Pageof 86
Nature Communications|February 23, 2016
Genome analysis of three Pneumocystis species reveals adaptation mechanisms to life exclusively in mammalian hostsLiang Ma, Zehua Chen, Da Wei Huang, et al.
Nature Immunology|January 5, 2021
Broadly effective metabolic and immune recovery with C5 inhibition in CHAPLE diseaseAhmet Ozen, Nurhan Kasap, Ivan Vujkovic-Cvijin, et al.
Eclinicalmedicine|January 2, 2023
Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trialKarolina Akinosoglou, Antigone Kotsaki, Ioanna-Maria Gounaridi, et al.
Research Square|March 30, 2023
Multiomics integration of 22 immune-mediated monogenic diseases reveals an emergent axis of human immune healthRachel Sparks, Nicholas Rachmaninoff, Dylan C Hirsch, et al.
Nature Medicine|July 3, 2024
A unified metric of human immune healthRachel Sparks, Nicholas Rachmaninoff, William W Lau, et al.
World Journal of Emergency Surgery : WJES|February 20, 2020
A proposal for a comprehensive approach to infections across the surgical pathwayMassimo Sartelli, Leonardo Pagani, Stefania Iannazzo, et al.
Nature Medicine|September 4, 2021
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trialEvdoxia Kyriazopoulou, Garyfallia Poulakou, Haralampos Milionis, et al.
Vaccine|September 4, 2023
Timeline kinetics of protective immunity to SARS-CoV-2 upon primary vaccination and humoral response to variants after booster doseMaria da Penha Gomes Gouvea, Ketty Lysie Libardi Lira Machado, Yasmin Gurtler Pinheiro de Oliveira, et al.
Vaccines|November 26, 2025
Third Booster Half Dose of ChAdOx1-nCov-19 Is Effective, Safe, and Induces Long-Duration Humoral and Cellular Immune Response to Omicron: 1-Year Follow-Up of Viana StudyNésio Fernandes de Medeiros-Junior, Maria da Penha Gomes Gouvea, Luiz Antônio Bastos Camacho, et al.
Thrombosis and Haemostasis|January 7, 2021
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST StudyAugusto Di Castelnuovo, Simona Costanzo, Andrea Antinori, et al.
Pageof 86